SEC Form 4 · accession 0001179110-19-003702
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James DArecca
Officer — SVP Chief Accounting Officer
Period of report
Mar 7, 2019
Accepted (ET)
Mar 11, 2019 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1 | Mar 7, 2019 | F | 359 | $143.00 | D | 7,146 | D | |
| Ordinary Shares, par value $0.0001F1 | Mar 8, 2019 | F | 113 | $145.06 | D | 7,033 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc.